A detailed history of Ifs Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Ifs Advisors, LLC holds 58 shares of OGN stock, worth $902. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58
Previous 58 -0.0%
Holding current value
$902
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 16, 2022

BUY
$28.67 - $37.13 $1,662 - $2,153
58 New
58 $1,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.96B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ifs Advisors, LLC Portfolio

Follow Ifs Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifs Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifs Advisors, LLC with notifications on news.